Stocks Hitting 52-Week Lows
The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.
NephroGenex (NASDAQ: NRX) shares reached a new 52-week low of $6.67. On Monday, NephroGenex posted a full-year net loss of $6.3 million, or $19.71 per share.
Bio-Path Holdings (NASDAQ: BPTH) shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period.
Akers Biosciences (NASDAQ: AKER) shares reached a new 52-week low of $3.85. Akers Biosciences' trailing-twelve-month ROE is -41.12%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.